Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News AHA 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Todd Neale

November 17, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Shelley Wood

March 30, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Michael O'Riordan

February 06, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Advertisement

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

Missed Opportunities: Many HF Patients Not Tested for CAD

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content